女性健康診断の世界市場:用途別(出生前検査、ダウン症候群、不妊症検査、妊娠検査、尿路感染症、骨粗鬆症、乳房、子宮頸部、卵巣癌検査)、エンドユーザー別(病院、ホームケア)

◆英語タイトル:Global Women’s Health Diagnostics Market Size study, by Application (Prenatal Testing, Down Syndrome, Fertility Test, Pregnancy Test, Urinary Tract Infections, Osteoporosis, Breast, Cervical, Ovarian Cancer Test), by End User (Hospitals, Home care) and Regional Forecasts 2019-2026
◆商品コード:BZW20FB174
◆発行会社(リサーチ会社):Bizwit Research & Consulting
◆発行日:2020年1月21日
◆ページ数:約200
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、日本、アメリカ、カナダ、イギリス、ドイツ、フランス、中国、インド、ブラジル、メキシコ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥529,650見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥668,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はBizwit Research & Consulting社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Bizwit Research & Consulting社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、女性健康診断の世界市場について調べ、エグゼクティブサマリー、市場の定義・範囲、市場動向、産業分析、用途別(出生前検査、ダウン症候群、不妊症検査、妊娠検査、尿路感染症、骨粗鬆症、乳房、子宮頸部、卵巣癌検査)分析、エンドユーザー別(病院、ホームケア)分析、地域別分析、競争状況などで構成されています。
・エグゼクティブサマリー
・市場の定義・範囲
・市場動向
・産業分析
・女性健康診断の世界市場:用途別(出生前検査、ダウン症候群、不妊症検査、妊娠検査、尿路感染症、骨粗鬆症、乳房、子宮頸部、卵巣癌検査)
・女性健康診断の世界市場:エンドユーザー別(病院、ホームケア)
・女性健康診断の世界市場:地域別
・競争状況
【レポートの概要】

Global Women’s Health Diagnostics Market is valued approximately USD 28 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 7.9% over the forecast period 2019-2026. Women are more susceptible to certain diseases, usually related to depression, osteoporosis, menstrual disorders, obesity, and autoimmune diseases. Women’s major health concerns are associated with the procreative system that incorporates polycystic ovarian syndrome, infertility, menopause and cancers such as cervical cancer, breast cancer, and urological disorders. As per the, National Institute of Health (NIH), about 40% of women deals with at least one UTI (urinary tract infection) in their lifetime. Further, as per the source, women are 30 times more likely than men to develop a UTI under the age of 50. Moreover, according to the study conducted by University of Chicago (2018), the rate of urinary incontinence is more in 60 & above-aged females which are estimated approximately 69% globally due to geriatric syndrome with age-related changes in physiology, comorbidity, medications and especially functional impairments. High incidence of infectious diseases in women coupled with rising number of chronic and lifestyle-related syndromes in women is increasing the adoption of diagnostics imaging procedures. These women’s health diagnostic tests involve various tests such as pregnancy and ovulation tests, breast cancer tests, ovarian cancer tests, and others. Thus, increasing number of women’s health related disorder is driving the market. Furthermore, improving healthcare infrastructure in emerging markets and growing number of regulatory approvals for immunoassay diagnostic techniques is expected to create significant growth opportunity in the market over the forecast period. However, lack of a skilled workforce coupled with high cost of diagnostic imaging systems impedes the growth of the market over the forecast period of 2019-2026.

The regional analysis of global Women’s Health Diagnostics market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the increasing prevalence of cancer among women coupled with the increasing incidences of lifestyle-oriented health disorders. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026. Factors such as rising awareness about women’s health disorder, government initiative and improving healthcare infrastructure would create lucrative growth prospects for the Women’s Health Diagnostics market across Asia-Pacific region.

Major market player included in this report are:
Siemens AG
Quest Diagnostics Inc.
Hologic, Inc.
F. Hoffmann-La Roche AG
Perkinelmer Inc.
Alere Inc.
GE Healthcare
Becton, Dickinson and Company
Abbott Laboratories
Biomérieux SA

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Application:
Prenatal Testing,
Down Syndrome
Fertility Test Pregnancy Test,
Urinary Tract Infections,
Osteoporosis,
Breast cancer testing
Cervical cancer testing
Ovarian Cancer Test

By End User:
Hospitals
Home care

By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026

Target Audience of the Global Women’s Health Diagnostics Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

【レポートの目次】

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Billion)
1.2.1. Women’s Health Diagnostics Market, by Region, 2017-2026 (USD Billion)
1.2.2. Women’s Health Diagnostics Market, by Application, 2017-2026 (USD Billion)
1.2.3. Women’s Health Diagnostics Market, by End- User, 2017-2026 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Women’s Health Diagnostics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Women’s Health Diagnostics Market Dynamics
3.1. Women’s Health Diagnostics Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Women’s Health Diagnostics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Women’s Health Diagnostics Market, by Application
5.1. Market Snapshot
5.2. Global Women’s Health Diagnostics Market by Application, Performance – Potential Analysis
5.3. Global Women’s Health Diagnostics Market Estimates & Forecasts by Application 2016-2026 (USD Billion)
5.4. Women’s Health Diagnostics Market, Sub Segment Analysis
5.4.1. Prenatal Testing
5.4.2. Down Syndrome
5.4.3. Fertility Test
5.4.4. Pregnancy Test
5.4.5. Urinary Tract Infections
5.4.6. Osteoporosis
5.4.7. Breast cancer testing
5.4.8. Cervical cancer testing
5.4.9. Ovarian Cancer Test
Chapter 6. Global Women’s Health Diagnostics Market, by End -User
6.1. Market Snapshot
6.2. Global Women’s Health Diagnostics Market by End User, Performance – Potential Analysis
6.3. Global Women’s Health Diagnostics Market Estimates & Forecasts by End User 2016-2026 (USD Billion)
6.4. Women’s Health Diagnostics Market, Sub Segment Analysis
6.4.1. Hospital
6.4.2. Home care
Chapter 7. Global Women’s Health Diagnostics Market, Regional Analysis
7.1. Women’s Health Diagnostics Market, Regional Market Snapshot
7.2. North America Women’s Health Diagnostics Market
7.2.1. U.S. Women’s Health Diagnostics Market
7.2.1.1. Application breakdown estimates & forecasts, 2016-2026
7.2.1.2. End- User breakdown estimates & forecasts, 2016-2026
7.2.2. Canada Women’s Health Diagnostics Market
7.3. Europe Women’s Health Diagnostics Market Snapshot
7.3.1. U.K. Women’s Health Diagnostics Market
7.3.2. Germany Women’s Health Diagnostics Market
7.3.3. Rest of Europe Women’s Health Diagnostics Market
7.4. Asia-Pacific Women’s Health Diagnostics Market Snapshot
7.4.1. China Women’s Health Diagnostics Market
7.4.2. India Women’s Health Diagnostics Market
7.4.3. Japan Women’s Health Diagnostics Market
7.4.4. Rest of Asia Pacific Women’s Health Diagnostics Market
7.5. Latin America Women’s Health Diagnostics Market Snapshot
7.5.1. Brazil Women’s Health Diagnostics Market
7.5.2. Mexico Women’s Health Diagnostics Market
7.6. Rest of The World Women’s Health Diagnostics Market

Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Siemens AG
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Quest Diagnostics Inc.
8.2.3. Hologic, Inc.
8.2.4. F. Hoffmann-La Roche AG
8.2.5. Perkinelmer Inc.
8.2.6. Alere Inc.
8.2.7. GE Healthcare
8.2.8. Becton, Dickinson and Company
8.2.9. Abbott Laboratories
8.2.10. Biomérieux SA
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

List of Tables
TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET
TABLE 3. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
TABLE 7. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY APPLICATION 2016-2026 (USD BILLION)
TABLE 8. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY END- USER 2016-2026 (USD BILLION)
TABLE 9. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 10. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 11. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 12. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 13. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 14. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 15. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 16. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 17. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 18. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 19. U.S. WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 20. U.S. WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 21. U.S. WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 22. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 23. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 24. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 25. UK WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 26. UK WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 27. UK WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 28. GERMANY WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 29. GERMANY WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 30. GERMANY WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 31. ROE WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 32. ROE WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 33. ROE WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 34. CHINA WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 35. CHINA WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 36. CHINA WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 37. INDIA WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 38. INDIA WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 39. INDIA WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 40. JAPAN WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 41. JAPAN WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 42. JAPAN WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 43. ROAPAC WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 44. ROAPAC WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 45. ROAPAC WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 46. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 47. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 48. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 49. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 50. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 51. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 52. ROLA WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 53. ROLA WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 54. ROLA WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 55. ROW WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 56. ROW WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 57. ROW WOMEN’S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[女性健康診断の世界市場:用途別(出生前検査、ダウン症候群、不妊症検査、妊娠検査、尿路感染症、骨粗鬆症、乳房、子宮頸部、卵巣癌検査)、エンドユーザー別(病院、ホームケア)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆